Table 1 Patient baseline characteristics
Characteristics0.003 group (n = 12)0.006 group (n = 12)p Value
Age (years)59 (3)58 (4)0.772
Male, n (%)9 (75)6 (50)0.400
Body mass index (kg/m2)30 (1)34 (2)0.260
Body surface area (m2)2 (0.1)2 (0.1)0.954
PTCA/thrombolytic agents12:011:11.000
Hypertension, n (%)5 (42)6 (50)1.000
Diabetes, n (%)3 (25)0 (0)0.214
Time to reperfusion (min)321 (72)253 (75)0.214
Creatine kinase-MB peak (ng/ml)217 (80)212 (50)0.926
Systolic blood pressure (mm Hg)127 (5)125 (8)0.544
Diastolic blood pressure (mm Hg)76 (4)78 (6)0.707
LV ejection fraction (%)42 (2) (n = 11)40 (4) (n = 10)0.972
LV end-systolic volume (ml/m2)60 (11) (n = 10)61 (9) (n = 9)1.000
LV end-diastolic volume (ml/m2)104 (18) (n = 10)96 (11) (n = 9)0.939
ACEI or ARB, n (%)1 (8)2 (17)1.000
β Blocker, n (%)3 (25)2 (17)1.000
  • Results are shown as mean (SEM) unless stated otherwise.

  • ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; LV, left ventricular; PTCA, percutaneous transluminal coronary angioplasty.